{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:57:24Z","timestamp":1788328644584,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-15-00245"],"award-info":[{"award-number":["19-15-00245"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-15-00245"],"award-info":[{"award-number":["19-15-00245"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10637-023-01332-z","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T12:02:56Z","timestamp":1674648176000},"page":"142-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2974-9555","authenticated-orcid":false,"given":"Alexander M.","family":"Scherbakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana K.","family":"Vorontsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8137-0625","authenticated-orcid":false,"given":"Alvina I","family":"Khamidullina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-1610","authenticated-orcid":false,"given":"Jasminka","family":"Mrdjanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-6619","authenticated-orcid":false,"given":"Olga E.","family":"Andreeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-0335","authenticated-orcid":false,"given":"Fedor B.","family":"Bogdanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0809-3710","authenticated-orcid":false,"given":"Diana I.","family":"Salnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-128X","authenticated-orcid":false,"given":"Vladimir","family":"Jurisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-5756","authenticated-orcid":false,"given":"Igor V.","family":"Zavarzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9480-3565","authenticated-orcid":false,"given":"Valerii Z.","family":"Shirinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"1332_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jfda.2016.02.014","volume":"24","author":"Y Shahbazi","year":"2016","unstructured":"Shahbazi Y, Malekinejad H, Tajik H (2016) Determination of naturally occurring estrogenic hormones in cow\u2019s and river buffalo\u2019s meat by HPLC-FLD method. J food drug Anal 24:457\u2013463","journal-title":"J food drug Anal"},{"key":"1332_CR2","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1093\/pch\/pxaa082","volume":"26","author":"PK Buddala","year":"2021","unstructured":"Buddala PK, Chandrasekaran V, Harichandrakumar KT (2021) A 3-day course of 1\u00a0mg\/kg versus 2\u00a0mg\/kg bodyweight prednisolone for 1- to 5-year-old children with acute moderate exacerbation of asthma: a randomized double-blind noninferiority trial. Paediatrics & child health 26:e189\u2013e193","journal-title":"Paediatrics & child health"},{"key":"1332_CR3","doi-asserted-by":"crossref","unstructured":"Ramos-Ram\u00edrez P, Tliba O (2022) Glucocorticoid Insensitivity in Asthma: The Unique Role for Airway Smooth Muscle Cells. International journal of molecular sciences 23 (16). D\u041eI:10.3390\/ijms23168966","DOI":"10.3390\/ijms23168966"},{"key":"1332_CR4","doi-asserted-by":"publisher","first-page":"e24418","DOI":"10.1097\/MD.0000000000024418","volume":"100","author":"M Jing","year":"2021","unstructured":"Jing M, Yu Q, Zhu B, Yuan F, Zhang J, Peng L, Lin W, Chen M (2021) Topical 0.05% clobetasol cream in the treatment of chronic hand eczema: a protocol for systematic review and meta-analysis. Medicine 100:e24418","journal-title":"Medicine"},{"key":"1332_CR5","doi-asserted-by":"crossref","unstructured":"Promelle V, Goeb V, Gueudry J (2021) Rheumatoid arthritis Associated Episcleritis and Scleritis: an update on treatment perspectives, Journal of clinical medicine. 10","DOI":"10.3390\/jcm10102118"},{"key":"1332_CR6","doi-asserted-by":"crossref","unstructured":"Verheijen EJA, Bonke CA, Amorij EMJ, Vleggeert-Lankamp CLA (2021) Epidural steroid compared to placebo injection in sciatica: a systematic review and meta-analysis, european spine journal: official publication of the european spine Society, the european spinal deformity Society, and the european section of the cervical spine Research Society","DOI":"10.1007\/s00586-021-06854-9"},{"key":"1332_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2020.18936","volume":"325","author":"K Cushing","year":"2021","unstructured":"Cushing K, Higgins PDR (2021) Management of Crohn Disease: a review. Jama 325:69\u201380","journal-title":"Jama"},{"key":"1332_CR8","doi-asserted-by":"publisher","first-page":"v69","DOI":"10.1093\/rheumatology\/keaa403","volume":"59","author":"G Ruiz-Irastorza","year":"2020","unstructured":"Ruiz-Irastorza G, Bertsias G (2020) Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs. Rheumatol (Oxford Engl 59:v69\u2013v81","journal-title":"Rheumatol (Oxford Engl"},{"key":"1332_CR9","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.2174\/1568026620666200924114827","volume":"20","author":"O Deeb","year":"2020","unstructured":"Deeb O, Nabulsi M (2020) Exploring multiple sclerosis (MS) and amyotrophic lateral scler osis (ALS) as neurodegenerative Diseases and their treatments: a review study. Curr Top Med Chem 20:2391\u20132403","journal-title":"Curr Top Med Chem"},{"key":"1332_CR10","doi-asserted-by":"crossref","unstructured":"Sood S, Bhatia GK, Seth P, Kumar P, Kaur J, Gupta V, Punia S, Tuli HS (2021) Efficacy and safety of New and emerging drugs for COVID-19: Favipiravir and Dexamethasone, Current pharmacology reports, 1\u20136","DOI":"10.1007\/s40495-021-00253-w"},{"key":"1332_CR11","doi-asserted-by":"crossref","unstructured":"Mauvais-Jarvis F, Klein SL, Levin ER (2020) Estradiol, progesterone, Immunomodulation, and COVID-19 outcomes, Endocrinology. 161","DOI":"10.1210\/endocr\/bqaa127"},{"key":"1332_CR12","doi-asserted-by":"publisher","first-page":"173854","DOI":"10.1016\/j.ejphar.2021.173854","volume":"894","author":"S Noreen","year":"2021","unstructured":"Noreen S, Maqbool I, Madni A (2021) Dexamethasone: therapeutic potential, risks, and future projection during COVID-19 pandemic. Eur J Pharmacol 894:173854","journal-title":"Eur J Pharmacol"},{"key":"1332_CR13","doi-asserted-by":"crossref","unstructured":"Ahmed MH, Hassan A (2020) Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review, SN comprehensive clinical medicine, 1\u201310","DOI":"10.1007\/s42399-020-00610-8"},{"key":"1332_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.38212\/2224-6614.3090","volume":"29","author":"WJ Chen","year":"2021","unstructured":"Chen WJ, Tsai JH, Hsu LS, Lin CL, Hong HM, Pan MH (2021) Quercetin blocks the aggressive phenotype of triple-negative breast cancer by inhibiting IGF1\/IGF1R-mediated EMT program. J food drug Anal 29:98\u2013112","journal-title":"J food drug Anal"},{"key":"1332_CR15","first-page":"61","volume":"58","author":"M Fremont-Smith","year":"1946","unstructured":"Fremont-Smith M (1946) The carcinogenic and Carcinostatic Effects of Estrogens on breast tissue. Trans Am Clin Climatological Association 58:61\u201370","journal-title":"Trans Am Clin Climatological Association"},{"key":"1332_CR16","doi-asserted-by":"crossref","unstructured":"Silberberg M, Silberberg R (1948) Age factor in estrogen-induced breast cancers of mice, Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine (New York, NY) 69, 438 \u2013 41","DOI":"10.3181\/00379727-69-16746"},{"key":"1332_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0014-2964(75)90119-X","volume":"11","author":"VC Jordan","year":"1975","unstructured":"Jordan VC, Koerner S (1975) Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor. Eur J cancer 11:205\u2013206","journal-title":"Eur J cancer"},{"key":"1332_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3109\/00498257309151594","volume":"3","author":"JM Fromson","year":"1973","unstructured":"Fromson JM, Pearson S, Bramah S (1973) The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals. Xenobiotica; the fate of foreign compounds in biological systems 3:693\u2013709","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"1332_CR19","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1530\/ERC-20-0335","volume":"28","author":"VC Jordan","year":"2021","unstructured":"Jordan VC (2021) 50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened? Endocrine-related cancer 28:R11\u2013r30","journal-title":"Endocrine-related cancer"},{"key":"1332_CR20","doi-asserted-by":"crossref","unstructured":"Wang L, Sharma A (2020) The Quest for Orally Available Selective Estrogen Receptor Degraders (SERDs), ChemMedChem 15, 2072\u20132097","DOI":"10.1002\/cmdc.202000473"},{"key":"1332_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-4731(84)90196-1","volume":"20","author":"H Rochefort","year":"1984","unstructured":"Rochefort H, Bardon S, Chalbos D, Vignon F (1984) Steroidal and nonsteroidal antiestrogens in breast cancer cells in culture. J steroid Biochem 20:105\u2013110","journal-title":"J steroid Biochem"},{"key":"1332_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s10517-013-2160-y","volume":"155","author":"AM Scherbakov","year":"2013","unstructured":"Scherbakov AM, Krasil\u2019nikov MA, Kushlinskii NE (2013) Molecular mechanisms of hormone resistance of breast cancer. Bull experimental biology Med 155:384\u2013395","journal-title":"Bull experimental biology Med"},{"key":"1332_CR23","first-page":"3583","volume":"43","author":"CK Osborne","year":"1983","unstructured":"Osborne CK, Boldt DH, Clark GM, Trent JM (1983) Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43:3583\u20133585","journal-title":"Cancer Res"},{"key":"1332_CR24","doi-asserted-by":"publisher","first-page":"121074","DOI":"10.1016\/j.lfs.2022.121074","volume":"310","author":"AG Mukherjee","year":"2022","unstructured":"Mukherjee AG, Wanjari UR, Nagarajan D, Vibhaa KK, Anagha V, Joshua Paul P, Tharani Priya T, Chakraborty R, Renu K, Dey A, Vellingiri B, Gopalakrishnan AV (2022) Letrozole: Pharmacology, toxicity and potential therapeutic effects. Life Sci 310:121074","journal-title":"Life Sci"},{"key":"1332_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/0022-4731(87)90166-X","volume":"27","author":"AM Brodie","year":"1987","unstructured":"Brodie AM, Coombes RC, Dowsett M (1987) Aromatase inhibitors: basic and clinical studies. J steroid Biochem 27:899\u2013903","journal-title":"J steroid Biochem"},{"key":"1332_CR26","first-page":"65","volume":"262","author":"ME Brandt","year":"1988","unstructured":"Brandt ME, Puett D, Garola R, Fendl K, Covey DF, Zimniski SJ (1988) Aromatase and aromatase inhibitors: from enzymology to selective chemotherapy. Progress in clinical and biological research 262:65\u201384","journal-title":"Progress in clinical and biological research"},{"key":"1332_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF00682741","volume":"30","author":"G Cocconi","year":"1994","unstructured":"Cocconi G (1994) First generation aromatase inhibitors\u2013aminoglutethimide and testololactone. Breast cancer research and treatment 30:57\u201380","journal-title":"Breast cancer research and treatment"},{"key":"1332_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/BF03350940","volume":"11","author":"F Sciarra","year":"1988","unstructured":"Sciarra F (1988) Anti-estrogens and aromatase inhibitors: tamoxifen and testolactone. J endocrinological Invest 11:755\u2013762","journal-title":"J endocrinological Invest"},{"key":"1332_CR29","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.2174\/1871520620666200627204105","volume":"20","author":"P Ratre","year":"2020","unstructured":"Ratre P, Mishra K, Dubey A, Vyas A, Jain A, Thareja S (2020) Aromatase inhibitors for the treatment of breast Cancer: a journey from the scratch. Anti-cancer agents in medicinal chemistry 20:1994\u20132004","journal-title":"Anti-cancer agents in medicinal chemistry"},{"key":"1332_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/B978-0-12-387817-5.00030-3","volume-title":"Drug-Induced Liver Disease (Third Edition)","author":"LD DeLeve","year":"2013","unstructured":"DeLeve LD (2013) Chap. 30 - Cancer chemotherapy. In: Kaplowitz N, DeLeve LD (eds) Drug-Induced Liver Disease (Third Edition). Academic Press, Boston, pp 541\u2013567"},{"key":"1332_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0022-5347(17)60352-5","volume":"109","author":"AJ Wein","year":"1973","unstructured":"Wein AJ, Murphy JJ (1973) Experience in the treatment of prostatic carcinoma with cyproterone acetate. J Urol 109:68\u201370","journal-title":"J Urol"},{"key":"1332_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.steroids.2018.05.008","volume":"136","author":"M Jabeen","year":"2018","unstructured":"Jabeen M, Choudhry MI, Miana GA, Rahman KM, Rashid U, Khan HU, Arshia, Sadiq A (2018) Synthesis, pharmacological evaluation and docking studies of progesterone and testosterone derivatives as anticancer agents. Steroids 136:22\u201331","journal-title":"Steroids"},{"key":"1332_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/14756360600748474","volume":"21","author":"M Cabeza","year":"2006","unstructured":"Cabeza M, Bratoeff E, Heuze I, Rojas A, Ter\u00e1n N, Ochoa M, Ram\u00edrez-Apan T, Ram\u00edrez E, P\u00e9rez V, Gracia I (2006) New progesterone derivatives as inhibitors of 5alpha-reductase enzyme and prostate cancer cell growth. J enzyme Inhib Med Chem 21:371\u2013378","journal-title":"J enzyme Inhib Med Chem"},{"key":"1332_CR34","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1093\/annonc\/mdt216","volume":"24","author":"W Jonat","year":"2013","unstructured":"Jonat W, Bachelot T, Ruhstaller T, Kuss I, Reimann U, Robertson JFR (2013) Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer. Annals of oncology: official journal of the European Society for Medical Oncology 24:2543\u20132548","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"key":"1332_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3109\/14756366.2014.895719","volume":"30","author":"M Cabeza","year":"2015","unstructured":"Cabeza M, Heuze Y, S\u00e1nchez A, Garrido M, Bratoeff E (2015) Recent advances in structure of progestins and their binding to progesterone receptors. J enzyme Inhib Med Chem 30:152\u2013159","journal-title":"J enzyme Inhib Med Chem"},{"key":"1332_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0959-8049(98)00388-8","volume":"35","author":"JF Robertson","year":"1999","unstructured":"Robertson JF, Willsher PC, Winterbottom L, Blamey RW, Thorpe S (1999) Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer. Eur J cancer 35:214\u2013218","journal-title":"Eur J cancer"},{"key":"1332_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.steroids.2018.06.013","volume":"138","author":"AM Scherbakov","year":"2018","unstructured":"Scherbakov AM, Zavarzin IV, Vorontsova SK, Hajra A, Andreeva OE, Yadykov AV, Levina IS, Volkova YA, Shirinian VZ (2018) Synthesis and evaluation of the antiproliferative activity of benzylidenes of 16-dehydroprogesterone series. Steroids 138:91\u2013101","journal-title":"Steroids"},{"key":"1332_CR38","doi-asserted-by":"crossref","unstructured":"Vorontsova SK, Yadykov AV, Scherbakov AM, Minyaev ME, Zavarzin IV, Mikhaevich EI, Volkova YA, Shirinian VZ (2020) Novel d-Annulated Pentacyclic Steroids: Regioselective Synthesis and Biological Evaluation in Breast Cancer Cells, Molecules (Basel, Switzerland) 25","DOI":"10.3390\/molecules25153499"},{"key":"1332_CR39","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1039\/D1CE01417J","volume":"24","author":"SK Vorontsova","year":"2022","unstructured":"Vorontsova SK, Zavarzin IV, Shirinian VZ, Bozhenko EI, Andreeva OE, Sorokin DV, Scherbakov AM, Minyaev ME (2022) Synthesis and crystal structures of D-annulated pentacyclic steroids: looking within and beyond AR signalling in prostate cancer. CrystEngComm 24:2089\u20132099","journal-title":"CrystEngComm"},{"key":"1332_CR40","first-page":"747","volume":"39","author":"M Iselt","year":"1989","unstructured":"Iselt M, Holtei W, Hilgard P (1989) The tetrazolium dye assay for rapid in vitro assessment of cytotoxicity. Arzneimittelforschung 39:747\u2013749","journal-title":"Arzneimittelforschung"},{"key":"1332_CR41","doi-asserted-by":"publisher","first-page":"42863","DOI":"10.1039\/C6RA06881B","volume":"6","author":"YA Volkova","year":"2016","unstructured":"Volkova YA, Antonov YS, Komkov AV, Scherbakov AM, Shashkov AS, Menchikov LG, Chernoburova EI, Zavarzin IV (2016) Access to steroidal pyridazines via modified thiohydrazides. RSC Adv 6:42863\u201342868","journal-title":"RSC Adv"},{"key":"1332_CR42","doi-asserted-by":"publisher","first-page":"109243","DOI":"10.1016\/j.cbi.2020.109243","volume":"330","author":"Y Shchegolev","year":"2020","unstructured":"Shchegolev Y, Sorokin D, Scherbakov A, Shunaev A, Andreeva O, Mikhaevich E, Gudkova M, Bure I, Berstein L, Nemtsova M, Krasil\u2019nikov M (2020) Upregulation of Akt\/Raptor signaling is associated with rapamycin resistance of breast cancer cells. Chemico-biological Interact 330:109243","journal-title":"Chemico-biological Interact"},{"key":"1332_CR43","doi-asserted-by":"crossref","unstructured":"Scherbakov AM, Stasevich OV, Salnikova DI, Andreeva OE, Mikhaevich EI (2020) Antiestrogenic and antiproliferative potency of secoisolariciresinol diglucoside derivatives on MCF-7 breast cancer cells, Natural product research, 1\u20137","DOI":"10.1080\/14786419.2020.1826479"},{"key":"1332_CR44","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S1097-2765(03)00090-X","volume":"11","author":"G Reid","year":"2003","unstructured":"Reid G, H\u00fcbner MR, M\u00e9tivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol cell 11:695\u2013707","journal-title":"Mol cell"},{"key":"1332_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-005-9075-x","volume":"100","author":"AM Scherbakov","year":"2006","unstructured":"Scherbakov AM, Lobanova YS, Shatskaya VA, Onopchenko OV, Gershtein ES, Krasil\u2019nikov MA (2006) Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells? Breast cancer research and treatment 100:1\u201311","journal-title":"Breast cancer research and treatment"},{"key":"1332_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"1332_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4161\/spmg.1.2.16606","volume":"1","author":"DD Mruk","year":"2011","unstructured":"Mruk DD, Cheng CY (2011) Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits. Spermatogenesis 1:121\u2013122","journal-title":"Spermatogenesis"},{"key":"1332_CR48","doi-asserted-by":"publisher","first-page":"116521","DOI":"10.1016\/j.bmc.2021.116521","volume":"53","author":"YA Piven","year":"2022","unstructured":"Piven YA, Yastrebova MA, Khamidullina AI, Scherbakov AM, Tatarskiy VV, Rusanova JA, Baranovsky AV, Zinovich VG, Khlebnicova TS, Lakhvich FA (2022) Novel O-acylated (E)-3-aryl-6,7-dihydrobenzisoxazol-4(5H)-one oximes targeting HSP90-HER2 axis in breast cancer cells. Bioorg Med Chem 53:116521","journal-title":"Bioorg Med Chem"},{"key":"1332_CR49","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1021\/acs.analchem.1c00188","volume":"93","author":"A Kapara","year":"2021","unstructured":"Kapara A, Findlay Paterson KA, Brunton VG, Graham D, Zagnoni M, Faulds K (2021) Detection of estrogen receptor alpha and Assessment of Fulvestrant activity in MCF-7 Tumor Spheroids using Microfluidics and SERS. Anal Chem 93:5862\u20135871","journal-title":"Anal Chem"},{"key":"1332_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0960-0760(92)90204-V","volume":"43","author":"AE Wakeling","year":"1992","unstructured":"Wakeling AE, Bowler J (1992) ICI 182,780, a new antioestrogen with clinical potential. J steroid Biochem Mol biology 43:173\u2013177","journal-title":"J steroid Biochem Mol biology"},{"key":"1332_CR51","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1016\/S0021-9258(19)43537-0","volume":"248","author":"SC Brooks","year":"1973","unstructured":"Brooks SC, Locke ER, Soule HD (1973) Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 248:6251\u20136253","journal-title":"J Biol Chem"},{"key":"1332_CR52","first-page":"S1","volume":"24","author":"MA Gallo","year":"1997","unstructured":"Gallo MA, Kaufman D (1997) Antagonistic and agonistic effects of tamoxifen: significance in human cancer. Seminars in oncology 24:S1\u201371","journal-title":"Seminars in oncology"},{"key":"1332_CR53","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/0008-5472.CAN-06-1020","volume":"67","author":"P Fan","year":"2007","unstructured":"Fan P, Wang J, Santen RJ, Yue W (2007) Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. Cancer Res 67:1352\u20131360","journal-title":"Cancer Res"},{"key":"1332_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/or.2014.3190","volume":"32","author":"R Viedma-Rodr\u00edguez","year":"2014","unstructured":"Viedma-Rodr\u00edguez R, Baiza-Gutman L, Salamanca-G\u00f3mez F, Diaz-Zaragoza M, Mart\u00ednez-Hern\u00e1ndez G, Esparza-Garrido R, Vel\u00e1zquez-Flores R, M. A., Arenas-Aranda D (2014) Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review). Oncol Rep 32:3\u201315","journal-title":"Oncol Rep"},{"key":"1332_CR55","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495\u2013516","journal-title":"Toxicol Pathol"},{"key":"1332_CR56","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s12038-012-9265-8","volume":"37","author":"Z Li","year":"2012","unstructured":"Li Z, Huang Y, Dong F, Li W, Ding L, Yu G, Xu D, Yang Y, Xu X, Tong D (2012) Swainsonine promotes apoptosis in human oesophageal squamous cell carcinoma cells in vitro and in vivo through activation of mitochondrial pathway. J Biosci 37:1005\u20131016","journal-title":"J Biosci"},{"key":"1332_CR57","doi-asserted-by":"publisher","first-page":"798639","DOI":"10.3389\/fcvm.2022.798639","volume":"9","author":"R Kumari","year":"2022","unstructured":"Kumari R, Ray AG, Mukherjee D, Chander V, Kar D, Kumar US, Bharadwaj PVPD, Banerjee SK, Konar A, Bandyopadhyay A (2022) Downregulation of PTEN promotes Autophagy via Concurrent reduction in apoptosis in Cardiac Hypertrophy in PPAR \u03b1(-\/-) mice. Front Cardiovasc Med 9:798639","journal-title":"Front Cardiovasc Med"},{"key":"1332_CR58","doi-asserted-by":"publisher","first-page":"622","DOI":"10.38212\/2224-6614.3387","volume":"29","author":"TC Cheng","year":"2021","unstructured":"Cheng TC, Sayseng JO, Tu SH, Juan TC, Fang CL, Liao YC, Chu CY, Chang HW, Yen Y, Chen LC, Ho YS (2021) Curcumin-induced antitumor effects on triple-negative breast cancer patient-derived xenograft tumor mice through inhibiting salt-induced kinase-3 protein. J food drug Anal 29:622\u2013637","journal-title":"J food drug Anal"},{"key":"1332_CR59","doi-asserted-by":"publisher","first-page":"11217","DOI":"10.1073\/pnas.96.20.11217","volume":"96","author":"M Sabbah","year":"1999","unstructured":"Sabbah M, Courilleau D, Mester J, Redeuilh G (1999) Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci U S A 96:11217\u201311222","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1332_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0022-1759(92)90305-D","volume":"153","author":"MG Ormerod","year":"1992","unstructured":"Ormerod MG, Collins MK, Rodriguez-Tarduchy G, Robertson D (1992) Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods. J immunological methods 153:57\u201365","journal-title":"J immunological methods"},{"key":"1332_CR61","first-page":"381","volume":"37","author":"C Pellicciari","year":"1993","unstructured":"Pellicciari C, Manfredi AA, Bottone MG, Schaack V, Barni S (1993) A single-step staining procedure for the detection and sorting of unfixed apoptotic thymocytes. Eur J histochemistry: EJH 37:381\u2013390","journal-title":"Eur J histochemistry: EJH"},{"key":"1332_CR62","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0026-895X(25)09073-X","volume":"49","author":"YH Ling","year":"1996","unstructured":"Ling YH, el-Naggar AK, Priebe W, Perez-Soler R (1996) Cell cycle-dependent cytotoxicity, G2\/M phase arrest, and disruption of p34cdc2\/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Pharmacol 49:832\u2013841","journal-title":"Mol Pharmacol"},{"key":"1332_CR63","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4161\/cbt.6.2.3577","volume":"6","author":"NM Weir","year":"2007","unstructured":"Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, Rajaram M, Tridandapani S, Anant S, Kuppusamy P (2007) Curcumin induces G2\/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating akt and p38 MAPK. Cancer biology & therapy 6:178\u2013184","journal-title":"Cancer biology & therapy"},{"key":"1332_CR64","doi-asserted-by":"publisher","first-page":"15658","DOI":"10.18632\/oncotarget.24585","volume":"9","author":"M Iyengar","year":"2018","unstructured":"Iyengar M, O\u2019Hayer P, Cole A, Sebastian T, Yang K, Coffman L, Buckanovich RJ (2018) CDK4\/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer. Oncotarget 9:15658\u201315672","journal-title":"Oncotarget"},{"key":"1332_CR65","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3389\/fonc.2019.00853","volume":"9","author":"Z Pan","year":"2019","unstructured":"Pan Z, Zhang X, Yu P, Chen X, Lu P, Li M, Liu X, Li Z, Wei F, Wang K, Zheng Q, Li D (2019) Cinobufagin induces cell cycle arrest at the G2\/M phase and promotes apoptosis in malignant melanoma cells. Front Oncol 9:853","journal-title":"Front Oncol"},{"key":"1332_CR66","doi-asserted-by":"publisher","first-page":"601468","DOI":"10.3389\/fphar.2020.601468","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang M, Qu J, Gao Z, Qi Q, Yin H, Zhu L, Wu Y, Liu W, Yang J, Huang X (2020) Timosaponin AIII induces G2\/M arrest and apoptosis in breast Cancer by activating the ATM\/Chk2 and p38 MAPK signaling pathways. Front Pharmacol 11:601468","journal-title":"Front Pharmacol"},{"key":"1332_CR67","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/1098-2744(200006)28:2<102::AID-MC6>3.0.CO;2-2","volume":"28","author":"W Wang","year":"2000","unstructured":"Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF (2000) Cell-cycle arrest at G2\/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 28:102\u2013110","journal-title":"Mol Carcinog"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-023-01332-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-023-01332-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-023-01332-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T15:10:58Z","timestamp":1744211458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-023-01332-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1332"],"URL":"https:\/\/doi.org\/10.1007\/s10637-023-01332-z","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"20 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}